Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2007-07-24 Regulatory Filings
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2007
Regulatory Filings
2007-07-24 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by QIAGEN N.V., which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. The content includes a press release about the expiration of a merger exchange offer and the intent to accept tendered shares, indicating an update on merger activity. The document is relatively short (2975 characters) and primarily provides an announcement of the merger offer status and related press release, rather than detailed merger documentation or full financial reports. Form 6-K filings typically serve as regulatory filings for foreign issuers to provide material information to the SEC and investors. Given the nature of the content and the form type, the best classification is Regulatory Filings (RNS), as it does not contain full merger documents (which would be MA or TAR), nor is it a full annual or interim report, nor a simple announcement of a report publication. It is a regulatory announcement about merger progress and tender offer status.
2007-07-23 English
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a letter from QIAGEN N.V. to the SEC requesting acceleration of effectiveness for a Registration Statement on Form F-4. It is not the Registration Statement itself, nor does it contain financial data or report content. The document is a regulatory communication related to a filing process, specifically an acceleration request for a registration statement. It is short (2039 characters) and serves as an announcement/request rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory communications that do not fit other categories.
2007-07-20 English
FORM 6-K
AGM Information Classification · 100% confidence The document is a Form 6-K filing by QIAGEN N.V., which includes detailed materials related to the Annual General Meeting (AGM) of Shareholders scheduled for June 20, 2007. It contains the Notice of the AGM, the agenda, proxy solicitation materials, explanatory notes, and references to the Annual Report 2006. The content focuses on the meeting logistics, agenda items such as adoption of annual accounts, reappointments of directors, and voting instructions. This is consistent with materials shared during an AGM rather than the full annual report itself or other filings. The document length (15,000 characters) and detailed meeting-related content confirm it is not a brief announcement or proxy statement alone but the full AGM information package. Therefore, the appropriate classification is AGM Information (AGM-R).
2007-07-20 English
AMENDMENT NO. 2 TO FORM F-4
Merger & Acquisition Classification · 100% confidence The document is titled 'Amendment No. 2 to Form F-4' and is a registration statement filed with the SEC under the Securities Act of 1933. It relates to an exchange offer and subsequent merger between QIAGEN N.V. and Digene Corporation. The Form F-4 is a registration statement used for securities issued in business combination transactions, such as mergers and acquisitions. The content includes detailed terms of the offer, merger agreement, conditions, risk factors, financial information, and legal matters related to the merger. This is not a simple announcement or proxy solicitation but a comprehensive filing related to a merger transaction. Therefore, the appropriate classification is 'Merger & Acquisition' (Code: MA).
2007-07-18 English
COMMENT LETTER DATED JULY 12, 2007 - NICK PANOS
Regulatory Filings
2007-07-17 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.